GB0325391D0 - Human monoclonal antibodies - Google Patents

Human monoclonal antibodies

Info

Publication number
GB0325391D0
GB0325391D0 GB0325391A GB0325391A GB0325391D0 GB 0325391 D0 GB0325391 D0 GB 0325391D0 GB 0325391 A GB0325391 A GB 0325391A GB 0325391 A GB0325391 A GB 0325391A GB 0325391 D0 GB0325391 D0 GB 0325391D0
Authority
GB
United Kingdom
Prior art keywords
monoclonal antibodies
human monoclonal
human
antibodies
monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0325391A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0304363A external-priority patent/GB2398783A/en
Application filed by Individual filed Critical Individual
Publication of GB0325391D0 publication Critical patent/GB0325391D0/en
Priority to DK04714866.3T priority Critical patent/DK1597280T4/en
Priority to AU2004215125A priority patent/AU2004215125B2/en
Priority to EP10183270A priority patent/EP2298804A3/en
Priority to EP04714866.3A priority patent/EP1597280B2/en
Priority to PCT/IB2004/001071 priority patent/WO2004076677A2/en
Priority to HUE04714866A priority patent/HUE015415T5/en
Priority to PT04714866T priority patent/PT1597280E/en
Priority to ES04714866.3T priority patent/ES2389930T5/en
Priority to AT04714866T priority patent/ATE556091T2/en
Priority to US11/719,835 priority patent/US8071371B2/en
Priority to SG2007171861A priority patent/SG181999A1/en
Priority to IL183370A priority patent/IL183370A/en
Priority to AU2011201553A priority patent/AU2011201553B2/en
Priority to US13/275,017 priority patent/US20120027768A1/en
Priority to US13/870,804 priority patent/US9290786B2/en
Priority to US15/018,688 priority patent/US20160160258A1/en
Priority to US15/985,229 priority patent/US20180327800A1/en
Ceased legal-status Critical Current

Links

GB0325391A 2003-02-26 2003-10-30 Human monoclonal antibodies Ceased GB0325391D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
SG2007171861A SG181999A1 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by ebv transformation of b cells
AU2004215125A AU2004215125B2 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by EBV transformation of B cells
ES04714866.3T ES2389930T5 (en) 2003-02-26 2004-02-26 Production of monoclonal antibodies by transformation with EBV of B cells
US11/719,835 US8071371B2 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by EBV transformation of B cells
EP10183270A EP2298804A3 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by EBV transformation of B cells
EP04714866.3A EP1597280B2 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by ebv transformation of b cells
PCT/IB2004/001071 WO2004076677A2 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by ebv transformation of b cells
HUE04714866A HUE015415T5 (en) 2003-02-26 2004-02-26 Monoclonal antibody production by ebv transformation of b cells
PT04714866T PT1597280E (en) 2003-02-26 2004-02-26 Monoclonal antibody production by ebv transformation of b cells
DK04714866.3T DK1597280T4 (en) 2003-02-26 2004-02-26 Preparation of monoclonal antibodies by EBV transformation of B cells
AT04714866T ATE556091T2 (en) 2003-02-26 2004-02-26 MONOCLONAL ANTIBODIES PRODUCTION THROUGH EBV TRANSFORMATION OF B CELLS
IL183370A IL183370A (en) 2003-02-26 2007-05-21 Method for producing immortalized memory b lymphocytes, immortalized b cell clone made by such method and monoclonal antibody obtained from an immortalized memory b lymphocyte or immortalized b cell clone for use in diagnosis or treatment of pathogenic or viral infection
AU2011201553A AU2011201553B2 (en) 2003-02-26 2011-04-06 Monoclonal antibody production by EBV transformation of B cells
US13/275,017 US20120027768A1 (en) 2003-02-26 2011-10-17 Monoclonal antibody production by ebv transformation of b cells
US13/870,804 US9290786B2 (en) 2003-02-26 2013-04-25 Monoclonal antibody production by EBV transformation of B cells
US15/018,688 US20160160258A1 (en) 2003-02-26 2016-02-08 Monoclonal antibody production by ebv transformation of b cells
US15/985,229 US20180327800A1 (en) 2003-02-26 2018-05-21 Monoclonal antibody production by ebv transformation of b cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0304363A GB2398783A (en) 2003-02-26 2003-02-26 A method for producing immortalised human B memory lymphocytes
GBGB0318431.4A GB0318431D0 (en) 2003-02-26 2003-08-06 Human monoclonal antibodies

Publications (1)

Publication Number Publication Date
GB0325391D0 true GB0325391D0 (en) 2003-12-03

Family

ID=29738118

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0325391A Ceased GB0325391D0 (en) 2003-02-26 2003-10-30 Human monoclonal antibodies

Country Status (1)

Country Link
GB (1) GB0325391D0 (en)

Similar Documents

Publication Publication Date Title
TWI367102B (en) Therapeutic human anti-il-1r1 monoclonal antibody
HK1077226A1 (en) Human monoclonal antibodies against cd25
IL200604A0 (en) Human monoclonal antibodies against cd30
EP1633785A4 (en) Human monoclonal antibodies against bacillusanthracis protective antigen
EP1616881A4 (en) Anti-mpl antibodies
IL173273A0 (en) Modified human igf-1r antibodies
IL175608A0 (en) Antibodies
AU2003259294A8 (en) Humanized antibodies against human 4-1bb
IL179672A (en) Human monoclonal anti-cd3 antibodies
HK1098825A1 (en) Human monoclonal antibodies against cd20
PT1599504E (en) Modified antibody
EP1494693A4 (en) Cripto-specific antibodies
PL375405A1 (en) Antibodies
IL172511A0 (en) Specific human antibodies
AU2003277832A8 (en) Humanized tissue factor antibodies
GB0306618D0 (en) Antibody
GB0226878D0 (en) Antibodies
GB0325391D0 (en) Human monoclonal antibodies
HK1209139A1 (en) Modified antibody
GB0329711D0 (en) Antibodies
SI1656391T1 (en) Modified human igf-1r antibodies
GB0218229D0 (en) Antibodies
GB0203018D0 (en) Antibodies
GB0210508D0 (en) Antibodies
GB0218230D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)